Therefore, suppressing the activity or decreasing the expression of ABCB1 could restore the sensitivity of MDR cancer cells to chemotherapeutic agents and allow for successful chemotherapy in patients with MDR due to ABCB1-overexpression [16]. This evidence concerns the gene ABCB1 and cancer.